Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Robert Kaminsky, MBA
Advertisement
Articles by Robert Kaminsky, MBA
In September 2009, the Pharmacy & Therapeutics Society gathered a study group of 12 managed care medical and pharmacy directors. The objective was to examine the impact that biomarker-based assays could have on the approaches payers and providers use to manage cancer.
Advertisement
Latest Updated Articles
- Hemophilia and Managed Care: Partnering to Achieve Cost-Effective Care
September 30th 2011
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
3
Pharmacist Outreach Doubles SGLT2 Inhibitor Uptake in CKD
4
Could VER-01 Redefine the Role of Cannabis in Chronic Pain Care?
5